These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8704639)

  • 1. [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances].
    Prozorovskiĭ VB; Velikova VD; Pshenkina NN; Vasilenko ET
    Eksp Klin Farmakol; 1996; 59(1):64-7. PubMed ID: 8704639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB; Livanov GA; Velikova VD; Afanas'ev VV; Pavlova LV
    Eksp Klin Farmakol; 1994; 57(5):13-5. PubMed ID: 7696893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aminostigmine-a novel drug against home poisoning].
    Bonitenko II; Safronov GA; Sosiukin AE; Pershin VN; Shpilenia LS
    Klin Med (Mosk); 1996; 74(8):58-61. PubMed ID: 9036214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
    Prozorovskiĭ VB; Sazonova AV
    Eksp Klin Farmakol; 1995; 58(5):57-61. PubMed ID: 8704593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Shchemeleva NI
    Eksp Klin Farmakol; 1992; 55(1):13-6. PubMed ID: 1305425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histamine blockers increase efficacy of specific antidote prophylaxis of intoxication by cholinesterase inhibitors in mice].
    Prozorovskiĭ VB; Skopichev VG; Ditiateva ZhA; Sazonova AV
    Eksp Klin Farmakol; 2000; 63(4):64-7. PubMed ID: 11022312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New data on the pharmacokinetics of aminostigmine].
    Prozorovskiĭ VB; Chepur SV; Vorob'ev-Desiatovskiĭ NV; Panov PB
    Eksp Klin Farmakol; 1998; 61(5):46-9. PubMed ID: 9854634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protection of mice by carbamates cholinesterase inhibitors against poisoning by armin and its dependence on certain physico-chemical indicators].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Kokushkina AV
    Vopr Med Khim; 1999; 45(6):525-9. PubMed ID: 10761219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the role of the brain cholinergic system in the mechanisms of dissociative learning.
    Azarashvili AA
    Neurosci Behav Physiol; 1997; 27(4):341-6. PubMed ID: 9252989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].
    Prozorovskiĭ VB; Iudkina NI
    Anesteziol Reanimatol; 1991; (1):25-6. PubMed ID: 1862957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bizerine: new anticholinesterase drug with selective gastrointestinal action].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Shchemeleva NI
    Eksp Klin Farmakol; 2010 Aug; 73(8):14-6. PubMed ID: 20919551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The selectivity and protective properties of m-cholinolytics in dichlorodivinylphosphate poisoning].
    Kosmachev AB; Iankhotova MB; Kosmacheva IM
    Eksp Klin Farmakol; 1992; 55(3):56-8. PubMed ID: 1458168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Criminal clozapine intoxications].
    Sliundin DG; Livanov AS; Anuchin VV; Bobrinskaia IG; Gutova EV
    Anesteziol Reanimatol; 2007; (4):61-4. PubMed ID: 17929492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of anticholinesterase activity and the effectiveness of anticholinesterase substances].
    Prozorovskĭ VB; Artem'ev VS; Tonkopiĭ VD; Konstorum MG
    Farmakol Toksikol; 1975; 38(4):402-6. PubMed ID: 1213123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the energy status of the brain structures in pharmacological exposures].
    Arkhipov VI; Bulantsev AIu
    Farmakol Toksikol; 1986; 49(3):115-9. PubMed ID: 2873050
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on Alzheimer drugs (galantamine).
    Raskind MA
    Neurologist; 2003 Sep; 9(5):235-40. PubMed ID: 12971834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of aminostigmine on the parameters of nonspecific resistance and immune system of the organism upon acute poisoning of benzyl 3-quinuclidylate].
    Zabrodskiĭ PF; Troshkin NM; Germanchuk VG; Sidel'nikova NM; Lim VG
    Eksp Klin Farmakol; 2005; 68(6):40-2. PubMed ID: 16405033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.